Navigation Links
Solstice Neurosciences Presents Escalating Dose Study at,International Congress in Istanbul, Turkey

Visual Analog Assessment (Patient Global, Investigator Global, Patient Pain)

Dr. Pappert reported, "In our study population, which we believe to be representative of people with CD in the United States, we found that escalating doses of Botulinum Toxin Type B were well-tolerated and efficacious. Using TWSTRS and the Visual Analog Assessments, we often saw improvement by the second week. Moreover, no treatment-related, serious adverse events were reported in any of the 145 subjects."

Shawn P. O'Brien, President and CEO of Solstice Neurosciences, commented, "The results reported by Dr. Pappert add to the ever-growing body of evidence that MYOBLOC can safely and effectively be used in a variety of CD patients for the pain and abnormal head position associated with this devastating and disabling condition."

About The Movement Disorder Society

Founded in 1985, The Movement Disorder Society (MDS) is a not-for-profit, international professional society of clinicians, scientists, and other healthcare professionals, who are interested in Parkinson's disease, related neurodegenerative and neurodevelopmental disorders, hyperkinetic movement disorders, and abnormalities in muscle tone and motor control. In 1992, the Society merged with the International Medical Society for Motor Disturbances. Its first International Congress was held in 1990.

About MYOBLOC

Myobloc(R) (Botulinum Toxin Type B) Injectable Solution was the first FDA-approved neurotoxin indicated for the neck pain and abnormal head position associated with cervical dystonia.

Before administering MYOBLOC, physicians should consult the full Prescribing Information. The most frequently reported adverse events with MYOBLOC are dry mouth, dysphagia, dyspepsia, and injection site pain. These adverse events are generally mild to moderate, transient, self-resolving, and more common with higher doses. MYOBLOC
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
2. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
3. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
4. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
5. Tranzyme Pharma Presents Initial Phase IIa Data for its Novel Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis
6. Novagali Pharma Presents at AACO the Results of its Pivotal Phase III Clinical Trial of Vekacia in Children Suffering From Vernal Keratoconjunctivitis
7. BioLife Solutions Presents Data on CryoStor at International Society for Cellular Therapy Annual Meeting
8. Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for the Treatment of Obesity at the American Diabetes Association 67th Scientific Session
9. Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its Ghrelin Antagonist Program at the American Diabetes Associations Annual Meeting
10. DiObex Presents Phase 2a Data of DIO-902 Demonstrating Trends of Improved Glycemic Control and Significant Reductions of LDL-Cholesterol and C-Reactive Protein
11. BioCryst Presents Phase I Peramivir Data at the Options for the Control of Influenza Conference
Post Your Comments:
(Date:6/20/2013)... 20, 2013 Today Moscamed made the ... of a new programme to control the dengue mosquito ... State of Bahia. In previous trials Moscamed have ... rapidly reduce the number of dengue mosquitoes in a town. ... these mosquitoes were reduced by 96% within 6 months and ...
(Date:6/19/2013)... Calif. , June 19, 2013 Pharmacyclics, ... announced that The New England Journal of Medicine ... 2 study evaluating the investigational oral Bruton,s tyrosine kinase ... lymphoma (MCL) online. These data suggested ibrutinib may be ... Results of a separate study examining ...
(Date:6/19/2013)...  Haemonetics Corporation (NYSE: HAE ) ... of its previously announced manufacturing transformation.  ... , Haemonetics has selected Sanmina Corporation (NASDAQ: ... medical devices currently manufactured in Braintree ... of integrated manufacturing solutions, components, products and repair, ...
Breaking Medicine Technology:Moscamed Launches Urban Scale Project Using Oxitec GM Mosquitoes in Battle Against Dengue 2Moscamed Launches Urban Scale Project Using Oxitec GM Mosquitoes in Battle Against Dengue 3Ibrutinib Phase 2 Study Results in Patients with Mantle Cell Lymphoma Published in The New England Journal of Medicine 2Ibrutinib Phase 2 Study Results in Patients with Mantle Cell Lymphoma Published in The New England Journal of Medicine 3Ibrutinib Phase 2 Study Results in Patients with Mantle Cell Lymphoma Published in The New England Journal of Medicine 4Ibrutinib Phase 2 Study Results in Patients with Mantle Cell Lymphoma Published in The New England Journal of Medicine 5Ibrutinib Phase 2 Study Results in Patients with Mantle Cell Lymphoma Published in The New England Journal of Medicine 6Haemonetics Announces Next Steps in Manufacturing Transformation 2Haemonetics Announces Next Steps in Manufacturing Transformation 3Haemonetics Announces Next Steps in Manufacturing Transformation 4
... chronic idiopathic,thrombocytopenic purpura increased and maintained platelet ... with extended treatment, ATLANTA, Dec. 10 ... safety and efficacy of its investigational,drug PROMACTA(TM) ... purpura (ITP).(1) These preliminary results from the,EXTEND ...
... trial specifically designed to evaluate erectile ... function in ED patients with dyslipidemia, ... specifically designed to evaluate erectile function in,erectile dysfunction (ED) ... treating ED, significantly improves the ability,of men with ED ...
Cached Medicine Technology:Long-Term Safety and Efficacy Data on Promacta(TM) (Eltrombopag) Presented at American Society of Hematology Annual Meeting 2Long-Term Safety and Efficacy Data on Promacta(TM) (Eltrombopag) Presented at American Society of Hematology Annual Meeting 3Long-Term Safety and Efficacy Data on Promacta(TM) (Eltrombopag) Presented at American Society of Hematology Annual Meeting 4New Study Shows LEVITRA Successfully Treats Erectile Dysfunction (ED) in Men with Dyslipidemia, Including High Cholesterol 2New Study Shows LEVITRA Successfully Treats Erectile Dysfunction (ED) in Men with Dyslipidemia, Including High Cholesterol 3New Study Shows LEVITRA Successfully Treats Erectile Dysfunction (ED) in Men with Dyslipidemia, Including High Cholesterol 4New Study Shows LEVITRA Successfully Treats Erectile Dysfunction (ED) in Men with Dyslipidemia, Including High Cholesterol 5
(Date:6/20/2013)... (PRWEB) June 20, 2013 Volume based ... to dramatically reduce the retail pricing of both it's ... meal replacement products. , Premier Natural Health’s whey ... natural food sources and are formulated to help maintain ... calorie intake and slow the aging process. , ...
(Date:6/20/2013)... 2013 TASC, a national leader ... new service to deal with funding the Patient-Centered ... Protection & Affordable Care Act (PPACA), the PCORI ... clinical effectiveness, and appropriateness" of different medical treatments. ... its own, with funding in part by employer-paid ...
(Date:6/20/2013)... 20, 2013 Millions of Britons are ... medical conditions because they do not brush their teeth ... Elgydium toothpaste. , Seven million Britons do not clean ... between brushes, latest data from the British Dental Health ... polled by the BDHF also admitted that they forgot ...
(Date:6/20/2013)... 20, 2013 David Icke, the highly visible ... and Radio station. , Fresh from the Bilderburg fringe ... is getting ready to launch ‘The Peoples Voice’ TV and ... is a fantastic opportunity for journalists to cover the stories ... areas of the globe. , Because this station is ...
(Date:6/20/2013)... (PRWEB) June 20, 2013 Michigan-based natural ... research work by chemist David R Hamilton which revealed ... or planned – resulted in the release of the ... entire body. Oxytocin is known as the ‘cardio protective’ ... in turn, good for heart health. , “Being kind ...
Breaking Medicine News(10 mins):Health News:Premier Natural Health, a Leading Provider of Natural Food Products and Herbal Solutions, Reduces Prices On Its Popular Whey Protein Product 2Health News:Premier Natural Health, a Leading Provider of Natural Food Products and Herbal Solutions, Reduces Prices On Its Popular Whey Protein Product 3Health News:TASC Service Helps Employers Handle New Burdens for Health Reimbursement Arrangement Plans 2Health News:Millions Are Risking Gum Disease, Warn Eludril And Elgydium 2Health News:Millions Are Risking Gum Disease, Warn Eludril And Elgydium 3Health News:Kindness Can Be Good for The Heart Says BioGirl Health Show 2Health News:Kindness Can Be Good for The Heart Says BioGirl Health Show 3
... body of scientific research about probiotics was presented today ... Here To Stay?" an annual Harvard Medical School ... cutting-edge topics are selected to provide education about emerging ... providers, and this year probiotics took center stage. ...
... data can make all the difference in controlling it. ... When should counties and states shut down airports, schools, and ... school and work? As America and the world ... says it may have a solution that can save both time ...
... Affiliates, Inc. (UCIA.PK) announced that on July 6, 2009, ... the United States District Court for the District of ... Executive Vice-President of Finance, Chief Financial Officer, and Secretary ... of the Securities and Exchange Act of 1934 and ...
... Into Service , , OTTAWA, July 8 /PRNewswire-FirstCall/ ... and radiopharmaceuticals, today continued to urge the Government of ... complete the MAPLE project to address the global shortage ... AECL that the 52-year-old National Research Universal (NRU) reactor ...
... following is a statement of Matthew L. Myers, President, Campaign ... ) , , We urge North Carolina legislators ... of North Carolina families by heeding Governor Bev Perdue,s call ... budget. While a larger cigarette tax increase would produce even ...
... 2009 Elsevier, a world-leading publisher of scientific, technical ... announce that PM&R -The journal of injury, ... journal of the American Academy of Physical Medicine and ... just six months after its launch in January 2009. ...
Cached Medicine News:Health News:Harvard Medical School Continues Education About Benefits of Probiotics 2Health News:Harvard Medical School Continues Education About Benefits of Probiotics 3Health News:Harvard Medical School Continues Education About Benefits of Probiotics 4Health News:Fighting the swine flu pandemic with mathematics 2Health News:UCI Medical Affiliates, Inc.'s Internal Investigation Leads to SEC Action and Criminal Charges Against Former Executive Officer 2Health News:UCI Medical Affiliates, Inc.'s Internal Investigation Leads to SEC Action and Criminal Charges Against Former Executive Officer 3Health News:UCI Medical Affiliates, Inc.'s Internal Investigation Leads to SEC Action and Criminal Charges Against Former Executive Officer 4Health News:MDS Nordion Continues to Urge Government of Canada to Complete MAPLE Project to Address Critical Medical Isotope Shortage 2Health News:MDS Nordion Continues to Urge Government of Canada to Complete MAPLE Project to Address Critical Medical Isotope Shortage 3Health News:MDS Nordion Continues to Urge Government of Canada to Complete MAPLE Project to Address Critical Medical Isotope Shortage 4Health News:North Carolina Should Increase Cigarette Tax by 50 Cents to Save Lives and Raise Revenue 2Health News:North Carolina Should Increase Cigarette Tax by 50 Cents to Save Lives and Raise Revenue 3Health News:PM&R accepted for abstracting and indexing in MEDLINE 2
Containing more than 600 full drug monographs, plus abbreviated monographs for combination drugs, orphan drugs and AIDS drugs in development, A to Z Drug Facts provides up-to-date information on more...
Updated for 2006 with more than 800 complete drug entries, this mobile reference provides instant access to all the drug information nurses need in day-to-day practice....
... System RSD 800 is an individually configurable ... tube type identification via cap recognition is ... sample tubes in a clearly organized workflow. ... customized and offer high capacity. The System ...
... RSD 800A is an individually configurable System ... tube type identification via cap recognition is ... sample tubes in a clearly organized workflow. ... customized and offer high capacity. The System ...
Medicine Products: